Funding for this research was provided by:
Cancer Research UK (C552/A17720)
Kay Kendall Leukaemia Fund (KKL1050)
Engineering and Physical Sciences Research Council (Synthetic Biology CTD)
Received: 17 February 2018
Accepted: 7 May 2018
First Online: 13 June 2018
: All mice were housed and treated in accordance with UK Home Office guidelines outlined in the Animals (Scientific Procedures) Act 1986.
: KDF, BC and LWS hold equity in PsiOxus Therapeutics Ltd. KW, FL, LS, AB and BC are employees of Psioxus Therapeutics Ltd. JL, EJJ, MRD, and SH declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.